Your session is about to expire
← Back to Search
Virtual Reality Therapy for Chronic Pain in Sickle Cell Disease
Study Summary
This trial will test a new virtual reality intervention for chronic pain among young adults with sickle cell disease.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have an injury in your eyes, face, head, or neck that makes it hard for you to use virtual reality comfortably.You have difficulties with thinking or learning.I am currently having thoughts about harming myself.I am a Black adult aged 18-50 with sickle cell disease.You have a history of losing consciousness or "blacking out."I have health conditions that could affect how I feel pain.I have a medical condition that often makes me feel nauseous or dizzy.You are extremely sensitive to flashing lights or movement.You are prone to feeling very uncomfortable in small or enclosed spaces, or when experiencing motion or digital motion.You have a vacation planned within the next three months.I have severe problems with my vision or hearing.I have major difficulties with moving or coordination.I can't use VR equipment because I can't turn my head or use my hands well.I have not had surgery in the last three months.You have a problem with alcohol or drugs and depend on them.I have had chronic pain not related to blood flow issues for more than 6 months.I can wear a VR headset and move my head in all directions.I can use my hands to operate VR equipment like a controller.I have epilepsy, migraines, or a condition that prevents VR use.I plan to start a new pain management method soon.You cannot see things in 3D.I have a heart condition or an implanted device like a pacemaker.
- Group 1: Active control Group
- Group 2: EaseVRx Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Do I fulfill the qualifications to join this research endeavor?
"The eligible candidates for this trial are those 18-50 years of age with anemia and sickle cell conditions. The medical study aims to enrol 72 participants."
Is this investigation actively searching for participants who are over 60 years of age?
"Eligible participants must be aged 18-50 years."
Is there an ongoing recruitment process for this clinical trial?
"As indicated on clinicaltrials.gov, this medical study is recruiting participants. This trial was first made public on October 27th 2021 and the information was most recently refreshed on April 19th 2022."
How many participants have enrolled in the research project?
"Affirmative. Clinicaltrials.gov indicates that the medical trial was first posted on October 27th 2021 and is actively searching for 72 participants from 2 locations to join its research cohort."
What are the main goals of this clinical research endeavor?
"The primary measure of this study's efficacy is the Change in Participant Engagement: Duration, which will be assessed on a daily basis over 8 weeks. Secondary outcomes include the Change in BRIEF Health Literacy (assessed by using a score-based tool ranging from 4 to 20), Change in Executive Function (measured with a 34-238 scale based on responses from never a problem to always a problem), and Change in Functional Activities of Daily Living (utilizing an assessment that ranges from 55 to > 70)."
Share this study with friends
Copy Link
Messenger